Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Buy
10,777
+543
+5% +$64.3K ﹤0.01% 2331
2025
Q4
$1.38M Buy
+10,234
New +$1.12M ﹤0.01% 2228

Other funds holding ABVX

Stifel Financial's ABVX Position: Q1 2026 in Review

Stifel Financial increased its Abivax (ABVX) stake by 5.3% in Q1 2026, buying an estimated $64.3K and bringing the position to 10,777 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2331.

Stifel Financial first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.38M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Stifel Financial held 10,777 shares of Abivax worth $1.2M as of Q1 2026.
  • Stifel Financial bought 543 Abivax shares in Q1 2026, an estimated $64.3K.
  • Abivax made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2331 holding.
  • Stifel Financial first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Stifel Financial's Abivax position peaked at $1.38M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.